Kidder Stephen W held its stake in shares of Colgate-Palmolive Company (NYSE:CL) during the first quarter, Holdings Channel reports. The fund owned 6,695 shares of the company’s stock at the end of the first quarter. Kidder Stephen W’s holdings in Colgate-Palmolive were worth $490,000 at the end of the most recent reporting period.
Several other large investors have also made changes to their positions in the company. Blue Chip Partners Inc. raised its stake in Colgate-Palmolive by 0.4% in the first quarter. Blue Chip Partners Inc. now owns 1,805 shares of the company’s stock worth $132,000 after buying an additional 8 shares in the last quarter. Alpha Windward LLC raised its stake in Colgate-Palmolive by 0.6% in the first quarter. Alpha Windward LLC now owns 2,829 shares of the company’s stock worth $207,000 after buying an additional 18 shares in the last quarter. Northstar Group Inc. raised its stake in Colgate-Palmolive by 0.4% in the first quarter. Northstar Group Inc. now owns 4,850 shares of the company’s stock worth $356,000 after buying an additional 20 shares in the last quarter. Savant Capital LLC raised its stake in Colgate-Palmolive by 0.3% in the first quarter. Savant Capital LLC now owns 10,526 shares of the company’s stock worth $770,000 after buying an additional 30 shares in the last quarter. Finally, Evanson Asset Management LLC raised its stake in Colgate-Palmolive by 0.3% in the first quarter. Evanson Asset Management LLC now owns 11,869 shares of the company’s stock worth $869,000 after buying an additional 32 shares in the last quarter. Hedge funds and other institutional investors own 73.85% of the company’s stock.
Shares of Colgate-Palmolive Company (NYSE CL) traded down 0.41% during mid-day trading on Friday, reaching $71.26. 2,023,502 shares of the company traded hands. The firm has a 50 day moving average of $72.84 and a 200-day moving average of $72.74. Colgate-Palmolive Company has a 52 week low of $63.43 and a 52 week high of $77.27. The stock has a market capitalization of $62.77 billion, a PE ratio of 26.48 and a beta of 0.80.
Colgate-Palmolive (NYSE:CL) last posted its earnings results on Friday, July 21st. The company reported $0.72 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.72. Colgate-Palmolive had a return on equity of 3,121.95% and a net margin of 15.83%. The company had revenue of $3.83 billion for the quarter, compared to analyst estimates of $3.89 billion. During the same quarter in the previous year, the firm earned $0.70 earnings per share. The firm’s quarterly revenue was down .5% compared to the same quarter last year. On average, equities research analysts expect that Colgate-Palmolive Company will post $2.89 EPS for the current fiscal year.
The firm also recently declared a quarterly dividend, which will be paid on Tuesday, August 15th. Stockholders of record on Tuesday, July 18th will be paid a dividend of $0.40 per share. The ex-dividend date is Friday, July 14th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 2.25%. Colgate-Palmolive’s payout ratio is 59.48%.
TRADEMARK VIOLATION NOTICE: This news story was originally reported by StockNewsTimes and is owned by of StockNewsTimes. If you are viewing this news story on another domain, it was copied illegally and republished in violation of US and international trademark & copyright laws. The legal version of this news story can be viewed at https://stocknewstimes.com/2017/08/12/kidder-stephen-w-holds-position-in-colgate-palmolive-company-cl.html.
A number of equities research analysts recently commented on the stock. Zacks Investment Research lowered shares of Colgate-Palmolive from a “hold” rating to a “sell” rating in a report on Thursday, July 27th. Jefferies Group LLC reiterated a “hold” rating and set a $79.00 price target (up from $77.00) on shares of Colgate-Palmolive in a report on Monday, July 24th. Deutsche Bank AG reiterated a “hold” rating and set a $75.00 price target on shares of Colgate-Palmolive in a report on Monday, July 24th. Wells Fargo & Company reiterated a “market perform” rating on shares of Colgate-Palmolive in a report on Monday, July 24th. Finally, BidaskClub lowered shares of Colgate-Palmolive from a “sell” rating to a “strong sell” rating in a report on Wednesday, July 12th. Two analysts have rated the stock with a sell rating, twelve have issued a hold rating and two have assigned a buy rating to the company. The stock currently has a consensus rating of “Hold” and a consensus target price of $75.82.
In other news, CFO Dennis J. Hickey sold 73,872 shares of the business’s stock in a transaction dated Thursday, August 3rd. The stock was sold at an average price of $71.80, for a total transaction of $5,304,009.60. Following the sale, the chief financial officer now owns 484,985 shares in the company, valued at $34,821,923. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, COO Justin Skala sold 74,374 shares of the business’s stock in a transaction dated Thursday, July 27th. The stock was sold at an average price of $72.51, for a total value of $5,392,858.74. Following the sale, the chief operating officer now owns 97,177 shares in the company, valued at approximately $7,046,304.27. The disclosure for this sale can be found here. Insiders have sold 203,969 shares of company stock worth $14,711,068 in the last 90 days. Insiders own 1.02% of the company’s stock.
Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Company (NYSE:CL).
Receive News & Ratings for Colgate-Palmolive Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive Company and related companies with MarketBeat.com's FREE daily email newsletter.